Although it is not clear whether the interactions among HCC cells, Tregs and CD8+ T cells present in human HCC patients, our study sheds some light in immunomodulation and provides a rational for designing immunotherapy for HCC. Here, CD8A is linked to hepatocellular carcinoma.